EUVIMEDEUVIMED entdecken
Fallbericht

Euglycemic diabetic ketoacidosis in type 2 diabetes mellitus patients following SGLT2i use: a case report

Abdullah M. Alzahrani, Ghaida I Alselami, Manal Naser Almutairy, Abdulaziz Bamusa, Belal Abdulahad Alturkistani

Annals of Middle Eastern Medicine · 18.08.2026 · 2 (3) · 276-280

DOI: 10.24911/amem.15-2842 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Middle Eastern Medicine, online erschienen am 15.08.2026. Verfasst von Abdullah M. Alzahrani und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While relatively rare in type 2 diabetes mellitus (T2DM), diabetic ketoacidosis (DKA) is a serious complication that occurs due to absolute or relative insulin deficiency. Euglycemic DKA (EDKA) is a variant of DKA where patients present with normal blood sugar levels. Recently, studies have reported increased incidence of EDKA associated with the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors, medications used to manage blood glucose.

Case Presentation: A 53-year-old man with newly diagnosed T2DM presented with severe nausea and vomiting 4 days after the initiation of empagliflozin/metformin. Laboratory evaluation revealed metabolic acidosis (pH 7.16, bicarbonate 12 mmol/l), elevated anion gap (21 mmol/l), and increased serum ketones, despite near-normal blood glucose levels (7.8 mmol/l, approximately 140 mg/dl). A diagnosis of EDKA was made. The patient was treated with intravenous fluids, insulin therapy, and electrolyte replacement, with discontinuation of the SGLT2 inhibitor. He showed rapid clinical and biochemical improvement and was discharged on insulin therapy, later transitioning to oral agents.

Conclusion

EDKA should be suspected in patients receiving SGLT2 inhibitors who present with unexplained metabolic acidosis, even in the absence of significant hyperglycemia. Early recognition and prompt management are essential to prevent complications. 

Zitieren

APA

Alzahrani, A. M., Alselami, G. I., Almutairy, M. N., Bamusa, A., & Alturkistani, B. A. (2026). Euglycemic diabetic ketoacidosis in type 2 diabetes mellitus patients following SGLT2i use: a case report. Annals of Middle Eastern Medicine, 2(3), 276-280. https://doi.org/10.24911/amem.15-2842

Vancouver

Alzahrani AM, Alselami GI, Almutairy MN, Bamusa A, Alturkistani BA. Euglycemic diabetic ketoacidosis in type 2 diabetes mellitus patients following SGLT2i use: a case report. Annals of Middle Eastern Medicine. 2026;2(3):276-280. doi:10.24911/amem.15-2842

BibTeX
@article{Alzahrani2026,
  author = {Alzahrani, Abdullah M. and Alselami, Ghaida I and Almutairy, Manal Naser and Bamusa, Abdulaziz and Alturkistani, Belal Abdulahad},
  title = {Euglycemic diabetic ketoacidosis in type 2 diabetes mellitus patients following SGLT2i use: a case report},
  journal = {Annals of Middle Eastern Medicine},
  year = {2026},
  volume = {2},
  number = {3},
  pages = {276--280},
  doi = {10.24911/amem.15-2842}
}
Kostenlos starten →